These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29232954)

  • 21. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.
    Kappelle PJ; Dallinga-Thie GM; Dullaart RP;
    Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic atorvastatin is as effective as the brand-name drug (LIPITOR
    Loch A; Bewersdorf JP; Kofink D; Ismail D; Abidin IZ; Veriah RS
    BMC Res Notes; 2017 Jul; 10(1):291. PubMed ID: 28716156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of atorvastatin therapy in ischaemic heart disease - effects on oxidized low-density lipoprotein and adiponectin.
    Miyagishima K; Hiramitsu S; Kato S; Kato Y; Kitagawa F; Teradaira R; Shinohara R; Mori K; Kimura H; Ueda T; Ohtsuki M; Morimoto S; Hishida H
    J Int Med Res; 2007; 35(4):534-9. PubMed ID: 17697531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
    Sonaje K; Lin YH; Juang JH; Wey SP; Chen CT; Sung HW
    Biomaterials; 2009 Apr; 30(12):2329-39. PubMed ID: 19176244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability.
    Kong R; Zhu X; Meteleva ES; Polyakov NE; Khvostov MV; Baev DS; Tolstikova TG; Dushkin AV; Su W
    Drug Deliv Transl Res; 2018 Oct; 8(5):1200-1213. PubMed ID: 30039497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized zein nanospheres for improved oral bioavailability of atorvastatin.
    Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
    Int J Nanomedicine; 2015; 10():4059-69. PubMed ID: 26150716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
    Diepeveen SH; Verhoeven GW; Van Der Palen J; Dikkeschei LD; Van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
    J Intern Med; 2005 May; 257(5):438-45. PubMed ID: 15836660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
    Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
    Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of alternate-day dosing versus daily dosing of atorvastatin.
    Jafari M; Ebrahimi R; Ahmadi-Kashani M; Balian H; Bashir M
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):123-6. PubMed ID: 12808485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.
    Awad K; Mikhailidis DP; Toth PP; Jones SR; Moriarty P; Lip GYH; Muntner P; Catapano AL; Pencina MJ; Rosenson RS; Rysz J; Banach M;
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):419-431. PubMed ID: 28741244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability.
    Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM
    Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407.
    Korolenko TA; Tuzikov FV; Cherkanova MS; Johnston TP; Tuzikova NA; Loginova VM; Filjushina EE; Kaledin VI
    Can J Physiol Pharmacol; 2012 Feb; 90(2):141-53. PubMed ID: 22320860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
    Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.